echoloc

NeuroDiscovery AI Tech Stack

AI platform for clinical trial acceleration and real-world neurology evidence

Biotechnology Research Atlanta, Georgia 11–50 employees Founded 2023 Privately Held

NeuroDiscovery AI runs a neurology-specialized platform built on a proprietary multimodal LLM trained on millions of patient records. The tech stack reflects a dual-track operation: modern web foundations (React, Next.js) paired with enterprise healthcare infrastructure (DICOM, PACS, HL7) and substantial ML depth (PyTorch, TensorFlow, spaCy, Transformers, multiple LLM variants). Active hiring spans data, research, and engineering roles, with acute pain points in data mapping and ETL—suggesting the platform is scaling data connectors across fragmented health systems faster than internal tooling can support.

Tech Stack 32 technologies

Core StackReact Next.js Angular Vue PyTorch TensorFlow AWS Elasticsearch Talend Apache Airflow Tableau JavaScript/TypeScript HTML5 CSS Git DICOM PACS GPT Llama 2 Mistral TruLens spaCy NLTK Transformers GCP Azure SQL HL7 Excel Google Sheets+2 more

What NeuroDiscovery AI Is Building

Challenges

  • Recruiting patients for clinical trials
  • Identifying patients who meet trial inclusion criteria
  • Financial accuracy
  • Budget vs actuals monitoring
  • Data accuracy and completeness
  • Data mapping issues
  • Etl issues
  • Connecting health data of millions of patients
  • Identifying new biomarkers

Active Projects

  • Next-generation imaging interfaces driving neurological ai workflows
  • Multimodal research
  • Patient analytics at scale
  • Revenue-generating patient recruitment projects
  • Data validation framework development
  • Mapping and etl issue resolution
  • Epidemiological and patient outcomes studies

Hiring Activity

Accelerating10 roles · 6 in 30d

Department

Data
3
Engineering
2
Research
2
Finance
1

Seniority

Mid
3
Director
2
Senior
2
Manager
1
Company intelligence

Find more companies like NeuroDiscovery AI by tech stack, pain points and active projects

Get started free

About NeuroDiscovery AI

NeuroDiscovery AI builds a clinical AI platform targeting neurology practices and trial sponsors. The company operates as a neurology-focused data and analytics business, pulling real-world patient data from large U.S. neurology practice groups, applying proprietary machine learning to accelerate clinical trial recruitment and generate real-world evidence for regulatory use. The product surface spans patient analytics, imaging workflows (DICOM/PACS integration), and outcome studies. Founded in 2023 with headquarters in Atlanta, the company is currently scaling toward mid-market clinical and pharmaceutical customers.

HeadquartersAtlanta, Georgia
Company Size11–50 employees
Founded2023
Hiring MarketsIndia, United States

Frequently Asked Questions

What tech stack does NeuroDiscovery AI use?

Frontend: React, Next.js, Angular, Vue. ML/NLP: PyTorch, TensorFlow, spaCy, NLTK, Transformers, GPT, Llama 2, Mistral, TruLens. Healthcare: DICOM, PACS, HL7. Data: SQL, Elasticsearch, Apache Airflow, Talend. Cloud: AWS, GCP, Azure.

What is NeuroDiscovery AI working on?

Current projects: next-generation imaging interfaces for neurological workflows, multimodal research, patient analytics at scale, revenue-generating patient recruitment, data validation frameworks, ETL issue resolution, and epidemiological outcome studies.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size